Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY22 Earnings Presentation
14 slides from Amrutanjan Health Care's earnings presentation, Aug 14, 2021
Slide 1: Exchange filing cover letter for investor presentation
AHCL/ SE/ 28 /2021-22 August 14, 2021 The National Stock Exchange of IndiaLimited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1* Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 Symbol : AMRUTANJAN Scrip Code: 590006 Dea
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation Quarter ended 30th June 2021 Date: 14th August 2021
Slide 3: Contents
Contents a. Business Update b. Q1 FY22 Performance c. Way Forward Investor Presentation | Quarter Ended 30th June 2021 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter Ended 30th June 2021 3
Slide 5: Business Update
Business Update • Certain secular consumer trends is continuing from last year - for instance purchase of health care products. • ORS category is at early stages of growth, like we saw with Sanitary napkins. • We are scaling Comfy steadily and this year saw new secondary sales at all-time high set f
Slide 6: Business Update - Comfy
Business Update - Comfy Actress Shraddha Kapoor has been roped in to endorse our Sanitary Napkin product “Comfy” Investor Presentation | Quarter Ended 30th June 2021 5
Slide 7: Q1 FY22 Performance
Q1 FY22 Performance Investor Presentation | Quarter Ended 30th June 2021 6
Slide 8: Financials – Q1 FY22
Financials – Q1 FY22 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 86.89 16.29 12.06 51.17 8.66 6.43 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Growth: 69.81% Growth: 88.11% Growth: 87.56% Investor Presentation | Quarter Ended 30th June 2021 7
Slide 9: Expenses – Q1 FY22
Expenses – Q1 FY22 (Rs. in Crores) Employee benefits expenses 12.25 9.14 Q1 FY22 Q1 FY21 Advt. and Selling expense Other expenses 9.32 8.28 4.98 3.56 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Investor Presentation | Quarter Ended 30th June 2021 8
Slide 10: Financials – Q1 FY22 – OTC Division
Financials – Q1 FY22 – OTC Division (Rs. in Crores) Gross Sales - OTC Notes: 74.59 47.09 • Key raw material prices including Menthol crystal price are lower when compared to Q1 FY21. Q1 FY22 Q1 FY21 • The prices of packing material are Growth: 58.40% higher when compared to Q1 FY21. Gross Sales - Co
Slide 11: Financials – Q1 FY22 – Beverage Division
Financials – Q1 FY22 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 12.02 Notes: 3.98 • Gross Margin has improved by 1,540 basis points when compared to Q1 FY21 mainly due to higher Electro Q1 FY22 Q1 FY21 plus volume. Growth: 202.01% • Advertisement spend is at 1.77 cr Gross Sales - El
Slide 12: Way Forward
Way Forward Investor Presentation | Quarter Ended 30th June 2021 11
Slide 13: Way Forward
Way Forward We remain focused on executing our key priorities: • Continue the growth rhythm of last year • Expand distribution • Go digital • Strengthen Beverage business • Costs control Investor Presentation | Quarter Ended 30th June 2021 12
Slide 14: Investor Presentation | Quarter Ended 30 th June 2021
Investor Presentation | Quarter Ended 30th June 2021 13
Amrutanjan Health Care — Q1 FY22 Earnings Presentation on 6ix